Inve US ▾
RDRDNT

RadNet (RDNT) Q4 FY25 earnings call: guidance and Q&A

Earnings call· Dec 2025 (Q4 FY25)· Health Care· Mar 2, 2026

Source: earnings call transcript

Executive summary

RadNet Q4 FY25 — Record Revenue and EBITDA Driven by Advanced Imaging and Strategic AI Acquisition

RadNet delivered a record-breaking Q4 FY25, fueled by robust demand for diagnostic imaging and strategic expansion in its Digital Health segment. The acquisition of Gleamer significantly bolsters the company's AI capabilities, positioning DeepHealth as a global leader in radiology clinical AI solutions. Management emphasizes AI's role in enhancing productivity and accuracy for an overburdened healthcare workforce, rather than replacing it, while also expanding into new markets and strengthening hospital partnerships.

Highlights

5

  • Total company revenue increased 14.8% to $547.7 million, marking a quarterly record.

  • Adjusted EBITDA increased 16.9% to $87.7 million, also a quarterly record.

  • Advanced imaging procedural volume grew 9.6% on a same-center basis, significantly driving margin and profitability.

  • Digital Health revenue grew 48.2% to $27.9 million, with Annual Recurring Revenue (ARR) projected to approach $140 million by the end of 2026.

  • The acquisition of Gleamer establishes DeepHealth as the largest provider of radiology clinical AI solutions worldwide.

Concerns

4

  • Adjusted EPS was flat at $0.23 per share compared to $0.24 per share in Q4 FY24.

  • 2026 guidance embeds over $30 million of same-center labor cost increases, representing approximately 4% growth.

  • 2026 guidance incorporates the impact from severe winter weather conditions in the Mid-Atlantic and Northeast regions during Q1.

  • The Gleamer acquisition is expected to result in an approximate $5 million EBITDA loss in 2026.

Guidance & targets

CategoryTargetConfidence
Imaging Center revenue growth
17% to 19%
high materiality
High
EBITDA growth
exceed that of revenue
high materiality
High
Free cash flow growth
29% to 41%
high materiality
High
Digital Health revenue growth
45% and 55%
high materiality
High
Digital Health Annual Recurring Revenue (ARR)
approach $140 million
high materiality
High
FDA clearances for Digital Health
minimum of four
medium materiality
High
Gleamer path to positive adjusted EBITDA
mid-2027
medium materiality
High
Digital Health revenues from RadNet's Imaging Center segment
decrease to about 33%
low materiality
High
De novo center openings
between 11 and 13 centers
medium materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Total Company
Record quarterly revenue and adjusted EBITDA.
$547.7 million14.8%—$87.7 million
Digital Health
Strong growth partially from iCAD acquisition; 25.9% growth without iCAD contribution.
Annual Recurring Revenue (ARR): $75.4 million (as of Dec 31, 2025)
$27.9 million48.2%—$4.9 million
Imaging Center
Revenue benefited from shift in modality mix towards advanced imaging, which drives higher revenue per procedure and improved adjusted EBITDA.
Aggregate advanced imaging procedural volume growth: 14.1%Same-center advanced imaging procedural volume growth: 9.6%Advanced imaging procedural volume as % of total: 28.6% (up 178 bps YoY)
————

RDNT operating KPIs by quarter

RDNT operating KPIs stated on its earnings calls, by fiscal quarter
KPIThis call Dec 2025 Q4 FY25 Mar 2026 Q1 FY26 Jun 2026 Q2 FY26Change vs prior quarter
Advanced imaging procedure share
28.6% During the fourth quarter, advanced imaging represented 28.6% of RadNet's procedural volume, an increase of 178 basis points from last year's same quarter. Source: earnings call transcript
29.3% During this year's first quarter, 29.3% of our procedural volume was from advanced imaging compared with 26.9% last year's first quarter, a difference of 235 basis points. Source: earnings call transcript
29.9% increasing from 27.5% of total procedure volume in last year's second quarter to 29.9% in this year's second quarter. Source: earnings call transcript
+0.6 pt
Imaging centers Health system partnerships
151 Currently, 151 of RadNet's 418 centers or 36.1% are held within health system partnerships. Source: earnings call transcript
155 Radnet purchased a 51% interest in existing partnership entity for approximately $17 million, including this newly commenced Trinity joint venture, 155 of RadNet's 440 centers or approximately 35.2% are held within health system partnerships. Source: earnings call transcript
157 As of the end of the second quarter, 157 of our now 442 centers or approximately 36% were held within health system partnerships. Source: earnings call transcript
+1.3%
Imaging centers
418 Currently, 151 of RadNet's 418 centers or 36.1% are held within health system partnerships. Source: earnings call transcript
440 Radnet purchased a 51% interest in existing partnership entity for approximately $17 million, including this newly commenced Trinity joint venture, 155 of RadNet's 440 centers or approximately 35.2% are held within health system partnerships. Source: earnings call transcript
442 As of the end of the second quarter, 157 of our now 442 centers or approximately 36% were held within health system partnerships. Source: earnings call transcript
+0.5%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Deals & partnerships

Gleamer Acquisition of a Paris-based leading radiology AI company to be integrated into DeepHealth. up to EUR 230 million

DeepHealth becomes the largest provider of radiology clinical AI solutions worldwide. Gleamer has over 700 customer contracts across 44 countries, 4 FDA-cleared and 6 CE-marked clinical AI solutions supporting over 25 clinical indications.

iCAD Acquisition of a company integrated into the DeepHealth product portfolio of solutions.

Acquired in July 2025.

See-Mode Acquisition of a company integrated into the DeepHealth product portfolio of solutions.

Acquired in 2025.

CIMAR Acquisition of a company integrated into the DeepHealth product portfolio of solutions.

Acquired in 2025.

Multiple sellers Acquisition of 13 imaging centers in Southwest Florida, expanding into new markets. ~$65 million

Expanded into 3 new markets in Southwest Florida.

Northwest Radiology Acquisition of 6 facilities, marking entry into Indiana. ~$9 million

Entry into Indiana with 6 facilities.

N/A Acquisition of a single imaging center in Virginia.

Single center acquisition in Virginia.

Risks & headwinds

Labor cost increases FY26

Over $30 million of same-center labor costs (approximately 4% growth) embedded in 2026 guidance.

Mitigation:Implementation of Digital Health solutions to automate manual processes, potentially leading to upside.

Severe winter weather conditions Q1 FY26 (January, February)

Impact on Q1 FY26 results in Mid-Atlantic and Northeast regions.

Mitigation:N/A (impact embedded in guidance, but less severe than prior year).

Gleamer acquisition EBITDA loss FY26

Approximately $5 million EBITDA loss in 2026.

Mitigation:Expected to achieve EBITDA positive by mid-2027 through growth and cost synergies.

What to watch in Q1 FY26

Digital Health ARR growth

Next quarter (Q1 FY26 results)
Current $75.4 million (as of Dec 31, 2025)
Target Progress towards $140 million by end of 2026

Why it matters

Indicates the pace of DeepHealth's commercialization and success of the AI strategy, crucial for future revenue and profitability.

At December 31, 2025, ARR for the Digital Health division was $75.4 million. We are anticipating ARR will approach $140 million at the end of 2026.

Find out whether RDNT delivers this. Inve re-checks your case every morning.

Q&A highlights

How does RadNet view AI's role in radiology (disruption vs. enhancement) and how does the Gleamer acquisition differentiate RadNet as the largest clinical AI asset owner?

Dr. Berger clarified that AI in healthcare is not about disruption or replacing employees, but rather enhancing productivity, accuracy, and improving the lifestyle of an overburdened workforce. He highlighted AI's proven ability to increase early detection of cancers by 20-22% in breast screening. The Gleamer acquisition is strategic for rounding out the portfolio in routine imaging, connecting provider networks, and addressing needs in non-traditional imaging settings like urgent care, where AI can improve care delivery and patient journeys.

“I don't think disruption is the right term to use for the opportunities and also, I shouldn't just call them opportunities, but the critical needs that radiology has as well as all of healthcare to transform itself and try to put less dependence on manual labor.”

asked by Brian Tanquilut · answered by Howard Berger

2 min read 6 chapters

Detailed narrative

Record Q4 and FY25 Performance

RadNet achieved its strongest quarter ever in Q4 FY25, reporting record revenue of $547.7 million, a 14.8% increase year-over-year, and record adjusted EBITDA of $87.7 million, up 16.9% year-over-year. The full year 2025 results met or exceeded original guidance levels for Imaging Center revenue, adjusted EBITDA, and free cash flow, demonstrating robust operational execution and market demand.

Advanced Imaging Growth and Modality Mix Shift

The company experienced significant growth in advanced imaging, with aggregate procedural volume increasing 14.1% and same-center volume growing 9.6% in Q4 FY25. Advanced imaging, including MRI, CT, and PET/CT, now accounts for 28.6% of RadNet's procedural volume, a 178 basis point increase from the prior year. This shift towards higher-acuity procedures is a key driver of revenue, margin, and overall profitability, supported by technological advancements and capital investments in equipment.

Strategic Investments and Expansion

In 2025, RadNet opened 7 de novo facilities to address backlogs and expand capacity, and expanded several joint venture partnerships. The company also made strategic acquisitions, including imaging facilities in California, New York, and Maryland. Post-year-end, RadNet further expanded its footprint by acquiring 13 centers in Southwest Florida, 6 facilities in Indiana, and a single center in Virginia, demonstrating a 'land and expand' strategy in new markets.

Gleamer Acquisition and AI Strategy

RadNet announced the acquisition of Paris-based Gleamer for up to EUR 230 million, integrating its AI solutions into DeepHealth. This acquisition positions DeepHealth as the largest provider of radiology clinical AI solutions worldwide, bringing over 700 customer contracts, 25+ clinical indications, and an expected $30 million in ARR for 2026. The strategy aims to leverage AI to enhance workflow efficiency, productivity, and accuracy in radiology, addressing labor shortages and improving patient outcomes.

Digital Health Growth and ARR

The Digital Health segment showed strong growth, with Q4 FY25 revenue increasing 48.2% to $27.9 million and full-year revenue reaching $92.7 million. The segment's Annual Recurring Revenue (ARR) stood at $75.4 million at year-end 2025 and is projected to approach $140 million by the end of 2026, driven by sales of the DeepHealth portfolio and Gleamer's contribution. RadNet anticipates a minimum of four FDA clearances for its AI solutions in 2026 across various clinical areas.

Financial Strength and Leverage Management

RadNet maintained a strong financial position at the end of 2025, with a cash balance of $776 million and a net debt to adjusted EBITDA leverage ratio of approximately 1.0x. Despite recent acquisitions in early 2026, the company remains committed to operating with low leverage, projecting a pro forma net debt to adjusted EBITDA ratio between 1.6x and 1.8x, reflecting disciplined capital allocation.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.